サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：キャピラリー電気泳動市場- 世界の産業規模、シェア、動向、機会、予測、2017年～2027年、コンポーネント別、モード別、用途別、エンドユーザー別、企業別、地域別分析
市場調査レポート
商品コード
1289642

キャピラリー電気泳動市場- 世界の産業規模、シェア、動向、機会、予測、2017年～2027年、コンポーネント別、モード別、用途別、エンドユーザー別、企業別、地域別分析

Capillary Electrophoresis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Component, By Mode, By Application, By End User, By Company and By Region
出版日: | 発行: TechSci Research | ページ情報: 英文 111 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

キャピラリー電気泳動市場- 世界の産業規模、シェア、動向、機会、予測、2017年～2027年、コンポーネント別、モード別、用途別、エンドユーザー別、企業別、地域別分析
出版日: 2023年06月01日
発行: TechSci Research
ページ情報: 英文 111 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界のキャピラリー電気泳動市場は、予測期間2023-2027年に目覚ましい成長を遂げると予測されています。

主な要因としては、各種がん、遺伝性疾患、感染症の増加、革新的な治療法や医薬品への需要の高まり、研究開発への投資の増加などがあり、市場の成長を後押ししています。キャピラリー電気泳動は、適切な電圧をかけることにより、電気泳動移動度に基づいて分析的にイオンを分離する分離法です。結果が早く、高分解能で分離できるため、主に使用されています。この電気泳動法は、バイオサイエンスや臨床研究で広く利用されています。その他の市場成長要因としては、研究開発活動の活発化、プロテオミクスやゲノミクス研究の増加、個別化医療の需要の増加、高齢化社会の進展、医療費の増加、創薬分野における電気泳動の応用拡大、合併や戦略的買収の増加、DNA分析ニーズの増加、技術進歩などが挙げられます。

がんの有病率の上昇

乳がん、子宮頸がん、肺がんなど、さまざまな種類のがんに罹患する人が増えていることが、市場の成長を後押ししています。米国心臓協会によると、心血管疾患は年間1,730万人の死亡の原因となっています。がんの発生率の上昇に伴い、早期診断と効果的な治療に対する需要も高まっており、これが市場の成長を後押ししています。例えば、2018年、国際がん研究機関（IARC）によると、世界中で1,700万人の新規がん患者が発生し、950万人のがん死者が出ています。

個別化医療への需要の高まり

現在、精密医療への需要が高まっており、これが市場の成長を後押しする重要な要因となっています。これは、最適な反応を得るために治療を調整し、有害事象を軽減する可能性があることに起因しています。精密医療とは、患者の遺伝学的情報やその他の重要な分子情報を利用して、効果的な治療を行うためのものです。例えば、2020年、進捗調査範囲と意義によると、特殊な医薬品は、その年のFDA承認新薬全体の約39％を占めると報告されています。

研究開発活動の増加

医療・生化学分野における研究開発活動数の増加が、市場の成長を後押ししています。遺伝性疾患、感染症、がんの増加により、治療が複雑化していることが、世界的に市場の成長を加速させています。ゲノミクスやプロテオミクスなど、さまざまな分野でのシーケンサー導入の増加や、シーケンサーのコスト削減が成長を後押ししています。さらに、政府や非政府組織による研究開発活動への多額の投資や、特定の疾患をターゲットとしたゲノム研究への助成金が、市場の成長を後押ししています。例えば、製薬会社のファイザーは、研究開発費を2019年の86億5,000万米ドルから2020年の94億米ドルに強化しました。

利用可能なカスタマイズ

与えられた市場データをもとに、TechSci Researchは企業の特定のニーズに応じてカスタマイズを提供します。本レポートでは、以下のカスタマイズオプションをご利用いただけます：

企業情報

  • 追加の市場プレイヤー（最大5社）の詳細な分析とプロファイリング

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 キャピラリー電気泳動の世界市場に対するCOVID-19の影響

第5章 顧客の声

第6章 キャピラリー電気泳動の世界市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • コンポーネント別（装置、消耗品、ソフトウェア）
    • モード別（キャピラリーゾーン電気泳動、キャピラリー電気クロマトグラフィ、その他）
    • 用途別（核酸分析／タンパク質分析）
    • エンドユーザー別（バイオテクノロジー・製薬企業、臨床検査機関、学術・研究機関、その他）
    • 企業別（2021年）
    • 地域別
  • 市場マップ

第7章 北米のキャピラリー電気泳動市場の展望

  • 市場規模と予測
  • 市場シェアと予測
  • 国別分析
    • 米国
    • カナダ
    • メキシコ

第8章 欧州のキャピラリー電気泳動装置の市場展望

  • 市場規模と予測
  • 市場シェアと予測
  • 国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第9章 アジア太平洋地域のキャピラリー電気泳動装置の市場展望

  • 市場規模と予測
  • 市場シェアと予測
  • 国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第10章 南米のキャピラリー電気泳動市場の展望

  • 市場規模と予測
  • 市場シェアと予測
  • 国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 中東・アフリカのキャピラリー電気泳動市場の展望

  • 市場規模と予測
  • 市場シェアと予測
  • 国別分析
    • 南アフリカ
    • サウジアラビア
    • UAE
    • トルコ
    • エジプト

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場の動向と発展市場の動向と開拓

第14章 競合情勢

  • QIAGEN NV
  • Thermo Fischer Scientific, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • PerkinElmer, Inc.
  • Merck KGaA
  • Promega Corporation
  • Shimadzu Corporation
  • LABGENE Scientific SA

第15章 戦略的推奨事項

目次
Product Code: 12992

The global capillary electrophoresis market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include growing incidences of various types of cancers, genetic disorders, and infectious diseases, growing demand for innovative therapies and drugs, and an increase in investments in R&D are propelling the growth of the market. Capillary electrophoresis is a separation method that separates ions analytically based on their electrophoretic mobility by applying a suitable voltage. It is used predominately because of the faster results and separates with high resolution. This electrophoresis technique is extensively used in biosciences and clinical research. The other factors supporting the market's growth are, rise in R&D activities, increased proteomics, and genomics research, increasing demand for personalized medicine, growing aging population base, increasing healthcare expenditure, increasing application of electrophoresis in the field of drug discovery, growing number of mergers and strategic acquisitions, increasing need for DNA analysis, and technological advancements.

Rising Prevalence of Cancer

The growing number of people suffering from different types of cancer, such as breast cancer, cervical, lung, and others, is augmenting the growth of the market. As per the American Heart Association, cardiovascular diseases cause 17.3 million deaths per year. Owing to the rise in incidences of cancer, the demand for early diagnosis and effective treatment is also rising, which fuels the growth of the market. For instance, in 2018, as per the International Agency for Research on Cancer (IARC), there were 17.0 million new cancer cases and 9.5 million cancer deaths across the world.

Increasing Demand for Personalized Medicine

Nowadays, the demand for precision medicine is rising, which is a key factor in bolstering the growth of the market. This is attributed to its potential to tailor therapy with the best response and to reduce any adverse events. It is basically used to have effective treatment by using a patient's genetics and other essential molecular information. For instance, in 2020, according to the scope and significance of the progress report, specialized medicines reported for about 39 percent of the total FDA-approved new drugs in the year.

Rise in Research and Development Activities

The rise in the number of R&D activities in the medical and biochemistry sector is fueling the growth of the market. Owing to the rise in genetic disorders, infectious diseases, and cancer, an increase in complexities in treatments is surging the growth of the market globally. Increasing adoption of sequencing in various fields, such as genomics and proteomics, and reduction in the cost of sequencing are supporting the growth. Furthermore, heavy investments by government and non-government organizations for research and development activities and grants for specific disease-targeted genomic research are fueling the growth of the market. For instance, pharmaceutical company Pfizer enhanced their R&D expenditure from $8.65 billion in 2019 to $9.4 billion in 2020.

Market Segmentation

The global capillary electrophoresis market is segmented into component, mode application, end user, and company. Based on components, the market is divided into instruments, consumables, and software. Based on mode, the market is divided into capillary zone electrophoresis, capillary electrochromatography, and others. Based on application, the market is divided into nucleic acid analysis and protein analysis. Based on nucleic acid analysis, the market is further segmented into DNA fragment analysis and RNA/mRNA analysis. Based on end-user, the market is divided into biotechnology & pharmaceutical companies, clinical laboratories, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising research and development (R&D) activities in the country.

Market Players

QIAGEN NV, Thermo Fischer Scientific, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, PerkinElmer, Inc., Merck KGaA, Promega Corporation, Shimadzu Corporation, and LABGENE Scientific SA are some of the leading companies operating in the market.

Report Scope

In this report, global capillary electrophoresis market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Capillary Electrophoresis Market, By Component:

  • Instruments
  • Consumables
  • Software

Capillary Electrophoresis Market, By Mode:

  • Capillary Zone Electrophoresis
  • Capillary Electro Chromatography
  • Others

Capillary Electrophoresis Market, By Application:

  • Nucleic Acid Analysis
    • DNA Fragment Analysis
    • RNA/mRNA Analysis
  • Protein Analysis

Capillary Electrophoresis Market, By End User:

  • Biotechnology & Pharmaceutical Companies
  • Clinical Laboratories
  • Academic & Research Institutions
  • Others

Capillary Electrophoresis Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Turkey
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Capillary Electrophoresis Market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Capillary Electrophoresis Market

5. Voice of Customer

6. Global Capillary Electrophoresis Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component (Instruments, Consumables, Software)
    • 6.2.2. By Mode (Capillary Zone Electrophoresis, Capillary Electro Chromatography, Others)
    • 6.2.3. By Application (Nucleic Acid Analysis v/s Protein Analysis)
      • 6.2.3.1. By Nucleic Acid Analysis (DNA Fragment Analysis v/s RNA/mRNA Analysis)
    • 6.2.4. By End User (Biotechnology & Pharmaceutical Companies, Clinical Laboratories, Academic & Research Institutions, Others)
    • 6.2.5. By Company (2021)
    • 6.2.6. By Region
  • 6.3. Market Map

7. North America Capillary Electrophoresis Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component (Instruments, Consumables, Software)
    • 7.2.2. By Mode (Capillary Zone Electrophoresis, Capillary Electro Chromatography, Others)
    • 7.2.3. By Application (Nucleic Acid Analysis v/s Protein Analysis)
      • 7.2.3.1. By Nucleic Acid Analysis (DNA Fragment Analysis v/s RNA/mRNA Analysis)
    • 7.2.4. By End User (Biotechnology & Pharmaceutical Companies, Clinical Laboratories, Academic & Research Institutions, Others)
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Capillary Electrophoresis Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
        • 7.3.1.2.2. By Mode
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. Canada Capillary Electrophoresis Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
        • 7.3.2.2.2. By Mode
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. Mexico Capillary Electrophoresis Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
        • 7.3.3.2.2. By Mode
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User

8. Europe Capillary Electrophoresis Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component (Instruments, Consumables, Software)
    • 8.2.2. By Mode (Capillary Zone Electrophoresis, Capillary Electro Chromatography, Others)
    • 8.2.3. By Application (Nucleic Acid Analysis v/s Protein Analysis)
      • 8.2.3.1. By Nucleic Acid Analysis (DNA Fragment Analysis v/s RNA/mRNA Analysis)
    • 8.2.4. By End User (Biotechnology & Pharmaceutical Companies, Clinical Laboratories, Academic & Research Institutions, Others)
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Capillary Electrophoresis Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
        • 8.3.1.2.2. By Mode
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany Capillary Electrophoresis Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
        • 8.3.2.2.2. By Mode
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. United Kingdom Capillary Electrophoresis Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
        • 8.3.3.2.2. By Mode
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. Italy Capillary Electrophoresis Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
        • 8.3.4.2.2. By Mode
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Capillary Electrophoresis Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component
        • 8.3.5.2.2. By Mode
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Asia-Pacific Capillary Electrophoresis Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component (Instruments, Consumables, Software)
    • 9.2.2. By Mode (Capillary Zone Electrophoresis, Capillary Electro Chromatography, Others)
    • 9.2.3. By Application (Nucleic Acid Analysis v/s Protein Analysis)
      • 9.2.3.1. By Nucleic Acid Analysis (DNA Fragment Analysis v/s RNA/mRNA Analysis)
    • 9.2.4. By End User (Biotechnology & Pharmaceutical Companies, Clinical Laboratories, Academic & Research Institutions, Others)
    • 9.2.5. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Capillary Electrophoresis Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
        • 9.3.1.2.2. By Mode
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. India Capillary Electrophoresis Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
        • 9.3.2.2.2. By Mode
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Japan Capillary Electrophoresis Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component
        • 9.3.3.2.2. By Mode
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User
    • 9.3.4. South Korea Capillary Electrophoresis Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Component
        • 9.3.4.2.2. By Mode
        • 9.3.4.2.3. By Application
        • 9.3.4.2.4. By End User
    • 9.3.5. Australia Capillary Electrophoresis Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Component
        • 9.3.5.2.2. By Mode
        • 9.3.5.2.3. By Application
        • 9.3.5.2.4. By End User

10. South America Capillary Electrophoresis Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component (Instruments, Consumables, Software)
    • 10.2.2. By Mode (Capillary Zone Electrophoresis, Capillary Electro Chromatography, Others)
    • 10.2.3. By Application (Nucleic Acid Analysis v/s Protein Analysis)
      • 10.2.3.1. By Nucleic Acid Analysis (DNA Fragment Analysis v/s RNA/mRNA Analysis)
    • 10.2.4. By End User (Biotechnology & Pharmaceutical Companies, Clinical Laboratories, Academic & Research Institutions, Others)
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Capillary Electrophoresis Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
        • 10.3.1.2.2. By Mode
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Capillary Electrophoresis Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
        • 10.3.2.2.2. By Mode
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Capillary Electrophoresis Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component
        • 10.3.3.2.2. By Mode
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Middle East and Africa Capillary Electrophoresis Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Component (Instruments, Consumables, Software)
    • 11.2.2. By Mode (Capillary Zone Electrophoresis, Capillary Electro Chromatography, Others)
    • 11.2.3. By Application (Nucleic Acid Analysis v/s Protein Analysis)
      • 11.2.3.1. By Nucleic Acid Analysis (DNA Fragment Analysis v/s RNA/mRNA Analysis)
    • 11.2.4. By End User (Biotechnology & Pharmaceutical Companies, Clinical Laboratories, Academic & Research Institutions, Others)
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Capillary Electrophoresis Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Component
        • 11.3.1.2.2. By Mode
        • 11.3.1.2.3. By Application
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Capillary Electrophoresis Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Component
        • 11.3.2.2.2. By Mode
        • 11.3.2.2.3. By Application
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Capillary Electrophoresis Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Component
        • 11.3.3.2.2. By Mode
        • 11.3.3.2.3. By Application
        • 11.3.3.2.4. By End User
    • 11.3.4. Turkey Capillary Electrophoresis Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Component
        • 11.3.4.2.2. By Mode
        • 11.3.4.2.3. By Application
        • 11.3.4.2.4. By End User
    • 11.3.5. Egypt Capillary Electrophoresis Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Component
        • 11.3.5.2.2. By Mode
        • 11.3.5.2.3. By Application
        • 11.3.5.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. QIAGEN NV
  • 14.2. Thermo Fischer Scientific, Inc.
  • 14.3. Agilent Technologies, Inc.
  • 14.4. Bio-Rad Laboratories, Inc.
  • 14.5. Danaher Corporation
  • 14.6. PerkinElmer, Inc.
  • 14.7. Merck KGaA
  • 14.8. Promega Corporation
  • 14.9. Shimadzu Corporation
  • 14.10. LABGENE Scientific SA

15. Strategic Recommendations